Results 71 to 80 of about 216,331 (260)

Interpreting the effects of DNA polymerase variants at the structural level

open access: yesMolecular Oncology, EarlyView.
Using MAVISp and molecular dynamics simulations, we analyzed over 60 000 missense variants in POLE and POLD1 from ClinVar, COSMIC, cBioPortal, and saturation mutagenesis. Identified mechanistic indicators, including stability, binding, and long‐range, enable structural interpretation, providing ACMG‐like evidence for possible reclassification of VUS ...
Matteo Arnaudi   +7 more
wiley   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Small scale software engineering

open access: yes, 1981
This thesis was submitted for the degree of Doctor of Philosophy and awarded by Brunel University.In computing, the Software Crisis has arisen because software projects cannot meet their planned timescales, functional capabilities, reliability levels and
Witty, Robert W
core  

Integration Strategies for Computational Science & Engineering Software

open access: yes, 2009
Second International Workshop on Software Engineering for Computational Science and Engineering May 23, 2009 Abstract: In order to make significant progress in solving challenging problems in Computational Science & Engineering (CS&E), we need to integrate a large amount of software written by different groups of experts.
openaire   +1 more source

Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patients

open access: yesMolecular Oncology, EarlyView.
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy   +10 more
wiley   +1 more source

Software Engineering and Computer Science website [PDF]

open access: yes, 2003
onlyThe Software Engineering and Computer Science Website was designed in response to the problems of the Department. Since, there is no current website the teacher’s post their announcement on the bulletin board were there is a possibility that the ...
Fernandez, Catherine   +4 more
core  

Informatics Related Branch's Curriculum and Role of Project Management

open access: yes, 2013
Misra, Sanjay/0000-0002-3556-9331The most important goal of the software industry is to produce successful product. During the process of production several times the product fails due to lack of proper management.
Akman, Kamil İbrahim   +5 more
core   +1 more source

Clinical performance of the urine‐based TERT promoter AbsoluteQ Digital PCR for non‐invasive detection of bladder cancer

open access: yesMolecular Oncology, EarlyView.
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel   +12 more
wiley   +1 more source

Market-Driven Software Project Through Agility: Requirements Engineering Perspective

open access: yes, 2009
Mishra, Deepti/0000-0001-5144-3811; Mishra, Alok/0000-0003-1275-2050Time-to-market and insufficient initial requirements are two major challenges that make requirement engineering for market-driven software projects different from bespoke software ...
Mıshra, Deepti   +3 more
core  

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy